EMERGEX VACCINES
Emergex Vaccines offer affordable, practical and effective vaccines on-demand, which are suited to low resource environments, disproportionately affected by pandemics. These vaccines will be used to create a clinical grade international vaccine repository that will act as a first line of defence in the case of existing and newly emerging infectious disease outbreaks.
EMERGEX VACCINES
Industry:
Biopharma Biotechnology Health Care
Founded:
2016-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.emergexvaccines.com
Total Employee:
1+
Status:
Active
Total Funding:
12.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving Apache
Current Employees Featured
Founder
Investors List
Department of Health and Social Care (DHSC)
Department of Health and Social Care (DHSC) investment in Grant - Emergex Vaccines
Vickers Venture Partners
Vickers Venture Partners investment in Series A - Emergex Vaccines
Innovate UK
Innovate UK investment in Grant - Emergex Vaccines
Trend Investment Group
Trend Investment Group investment in Seed Round - Emergex Vaccines
Official Site Inspections
http://www.emergexvaccines.com Semrush global rank: 3.51 M Semrush visits lastest month: 4.21 K
- Host name: digitaltrading.co.uk
- IP address: 5.101.171.102
- Location: Rugby United Kingdom
- Latitude: 52.3518
- Longitude: -1.2778
- Timezone: Europe/London
- Postal: CV22
More informations about "Emergex Vaccines"
Emergex Vaccines - Crunchbase Company Profile
Emergex Vaccines may be growing as evidenced by a series of recent developments. The company has secured a contract worth £1.79 million with the UK Department of Health and Social Care's UK Vaccine Network, which …See details»
EMERGEX VACCINES LIMITED - Companies House
EMERGEX VACCINES LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Emergex Vaccines - LinkedIn
Emergex Vaccines | 1,746 followers on LinkedIn. A UK biotechnology company developing T cell-priming immune set-point candidates against infectious diseases. | Emergex, a clinical-stage, …See details»
Emergex Vaccines Holding Limited Asset Profile | Preqin
Founded in 2016 and based in Abingdon, UK, Emergex Vaccines Holding Limited operates as a biopharmaceutical company that provides vaccines for viral and bact...See details»
Emergex Vaccines - EU-Startups
Mar 4, 2022 Emergex focuses on developing vaccines that prevent virulent diseases such as Zika, Dengue Fever, Ebola and even pandemic Flu. The company’s set-point vaccines deliver …See details»
Emergex Vaccines Holding - e27 Startup Profile
Emergex Vaccines is a privately held company focusing on the development of medicines against viral and bacterial infectious diseases, using purely synthetic non-biological components that …See details»
Emergex to start Phase I trials of T-cell priming vaccine for Dengue
Jun 30, 2021 Emergex Vaccines, a UK-based biotech company, has received approval to initiate a Phase I clinical trial for its Dengue Fever vaccine candidate. The company develops …See details»
Emergex appoints U.S. Federal Government experts The Conafay …
Jul 16, 2018 Find out more online at www.emergexvaccines.com. About The Conafay Group LLC The Conafay Group works with life science companies and organizations to develop and …See details»
Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio ...
Jan 5, 2021 PRESS RELEASE Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine * Agreement provides a …See details»
Emergex COVID-19 vaccine gets human trials | CTV News
Nov 16, 2021 A U.K. company that developed a new COVID-19 vaccine intended to be delivered via a small skin patch with microneedles has been granted approval for human trials.See details»
Emergex T Cell-Priming Vaccine Candidate for ... - Morningstar
Oct 2, 2024 Emergex Storme Moore-Thornicroft, Executive Director & Chief Operating Officer Phone: +44 (0) 1235 527589 Email: [email protected] Media Inquiries Rachelle …See details»
Emergex And Saudi Arabia's Vaccine Industrial Company (VIC) …
Oct 5, 2023 <p>Emergex Vaccines Holding Limited (‘Emergex’, or the ‘Company’) a clinical-stage biotechnology company on the forefront of …See details»
GlobeNewswire - Fox 8 Cleveland WJW
May 17, 2022 PRESS RELEASE Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle Patch …See details»
Emergex obtains approval to commence Phase I trial of Covid-19 …
Nov 16, 2021 The company expects to dose the first subject with the first dose of the vaccine in January 2022. Apart from safety and tolerability, the trial will offer information on CD8+ T-Cell …See details»
NanoPass's intradermal delivery platform used in Emergex's next ...
NES ZIONA, Israel, Jan. 26, 2022 /PRNewswire/ -- Intradermal COVID-19 vaccination studies are emerging in a global effort to use available doses more effectively by harnessing skin immunity …See details»
Emergex Vaccines Raises US$11 million to Advance Pipeline of …
Nov 18, 2020 Emergex Vaccines Raises US$11 million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases · Investor support further endorsement of vaccine …See details»
Emergex Vaccines - Company Profile - Tracxn
Nov 5, 2024 Emergex Vaccines - Developer T-cell Vaccines for treating viral and bacterial infections. Raised a total funding of $30M over 6 rounds from 3 investors. Valued at $174M. …See details»
Canada to donate almost 18 million surplus AstraZeneca doses to …
Jul 13, 2021 Canada is donating 17.7 million doses of the AstraZeneca coronavirus vaccine to help inoculate people in low- and middle-income countries, federal ministers announced Monday.See details»
Emergex T Cell-Priming Vaccine Candidate for ... - The Manila Times
Oct 2, 2024 Professor Thomas Rademacher, Co-Founder and Chief Executive Officer, Emergex, said "We are thrilled that our immunotherapy candidate for Betacoronaviruses, which has …See details»
What is COVAX and why is Canada getting backlash for receiving …
Feb 5, 2021 COVAX is a global vaccine-sharing initiative jointly co-ordinated by the World Health Organization, the Coalition for Epidemic Preparedness Innovations, and Gavi, The Vaccine …See details»